These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 31247469)

  • 1. A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
    Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q
    Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
    Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
    J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas.
    Chen J; Li Y; Han X; Pan Y; Qian X
    Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
    Patil V; Mahalingam K
    Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
    Xiao H; Bai J; Yan M; Ji K; Tian W; Liu D; Ning T; Liu X; Zou J
    World Neurosurg; 2019 Jun; 126():e765-e772. PubMed ID: 30853516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.
    Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W
    Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma.
    Liu W; Zou J; Ren R; Liu J; Zhang G; Wang M
    Technol Cancer Res Treat; 2021; 20():1533033821992084. PubMed ID: 33550903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
    Wu Y; Peng Z; Gu S; Wang H; Xiang W
    Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic power of a lipid metabolism gene panel for diffuse gliomas.
    Wu F; Zhao Z; Chai RC; Liu YQ; Li GZ; Jiang HY; Jiang T
    J Cell Mol Med; 2019 Nov; 23(11):7741-7748. PubMed ID: 31475440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.
    Xiao K; Liu Q; Peng G; Su J; Qin CY; Wang XY
    PeerJ; 2020; 8():e8312. PubMed ID: 31921517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a prognostic gene expression signature for lower-grade glioma following surgery and adjuvant radiotherapy.
    Qian DC; Marascio JA; Tobillo R; Lorenz JW; McCall NS; Neill SG; Hoang KB; Olson JJ; Eaton BR; Shu HG; Zhong J
    Radiother Oncol; 2022 Oct; 175():93-100. PubMed ID: 35998839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes.
    Li J; Wang J; Liu D; Tao C; Zhao J; Wang W
    Front Immunol; 2022; 13():1018942. PubMed ID: 36341390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort.
    Liu WR; Li CY; Xu WH; Liu XJ; Tang HD; Huang HN
    Aging (Albany NY); 2020 Jul; 12(13):13684-13700. PubMed ID: 32658870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.